Paper · 2012 · Open access

Current status of clozapine in the United States.

Deanna L. Kelly, Heidi J. Wehring, Gopal R. Vyas

PubMed Central, 24(2), 110–113 · Published 1 April 2012 · DOI 10.3969/j.issn.1002-0829.2012.02.007

Open PDFView at the publisherCite this paper

In brief

“Current status of clozapine in the United States.” is a 2012 paper by Deanna L. Kelly and 2 co-authors, published in PubMed Central. OpenAlex counts 22 citations as of 20 November 2026. It is open access under a CC BY-NC-SA licence: the full text is free to read at PubMed Central.

Citations
22
Most cited in
2017 (3)
Field-weighted impact
0.36
References
36
Authors
3

Abstract

Clozapine is the only antipsychotic in the United States that has been approved by the Food and Drug Administration (FDA) for treatment-resistant schizophrenia. It provides effective treatment even when patients do not respond to other second-generation antipsychotics.[1] It also remains the most effective antipsychotic available. No existing first or second-generation antipsychotic has been consistently found to be as effective as clozapine monotherapy in treatment-resistant patients.[2-6] Among patients who entered Phase 2 of the Clinical Antipsychotic Trial of Intervention Effectiveness (CATIE) because of lack of efficacy in Phase 1 of the study, those treated with clozapine (open label) averaged significantly greater time to treatment discontinuation (10.5 months)

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Kelly, D. L., Wehring, H. J., & Vyas, G. R. (2012). Current status of clozapine in the United States. PubMed Central, 24(2), 110–113. https://doi.org/10.3969/j.issn.1002-0829.2012.02.007

MLA 9

Kelly, Deanna L., et al. “Current status of clozapine in the United States.” PubMed Central, vol. 24, no. 2, 2012, pp. 110–113. https://doi.org/10.3969/j.issn.1002-0829.2012.02.007.

Chicago

Kelly, Deanna L., Heidi J. Wehring, and Gopal R. Vyas. 2012. “Current status of clozapine in the United States.” PubMed Central 24 (2): 110–113. https://doi.org/10.3969/j.issn.1002-0829.2012.02.007.

Harvard

Kelly, D. L., Wehring, H. J. and Vyas, G. R. (2012) ‘Current status of clozapine in the United States.’, PubMed Central, 24(2), pp. 110–113. doi:10.3969/j.issn.1002-0829.2012.02.007.

IEEE

D. L. Kelly, H. J. Wehring, and G. R. Vyas, “Current status of clozapine in the United States.,” PubMed Central, vol. 24, no. 2, pp. 110–113, 2012, doi: 10.3969/j.issn.1002-0829.2012.02.007.

BibTeX

@article{kelly2012current,
  title     = {{Current status of clozapine in the United States.}},
  author    = {Kelly, Deanna L. and Wehring, Heidi J. and Vyas, Gopal R.},
  journal   = {PubMed Central},
  year      = {2012},
  volume    = {24},
  number    = {2},
  pages     = {110--113},
  doi       = {10.3969/j.issn.1002-0829.2012.02.007},
  url       = {https://doi.org/10.3969/j.issn.1002-0829.2012.02.007}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
201511
201622
201733
201822
201933
202022
202233
202322
202422
202611

Its field-weighted citation impact is 0.36: it has been cited 0.36 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment

  • clozapine
  • treatment-resistant schizophrenia
  • antipsychotic efficacy
  • atypical antipsychotics
  • typical antipsychotics
  • CATIE trial
  • FDA approval
  • time to treatment discontinuation

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Kelly, D. L., Wehring, H. J., & Vyas, G. R. (2012). Current status of clozapine in the United States. PubMed Central, 24(2), 110–113. https://doi.org/10.3969/j.issn.1002-0829.2012.02.007

How many times has this paper been cited?

22 times, according to OpenAlex on 20 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at PubMed Central: sign in and open the PDF from this page.

Who wrote this paper?

Deanna L. Kelly, Heidi J. Wehring, Gopal R. Vyas.

What is the DOI of this paper?

10.3969/j.issn.1002-0829.2012.02.007, permanently at https://doi.org/10.3969/j.issn.1002-0829.2012.02.007. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 20 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.